Health-care company stocks fell as U.S. regulators look to crack down on prices and companies battle over market share of popular drugs. The Federal Trade Commission sued the drug middlemen that ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of insulin ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...
The agency said it filed a complaint in its administrative court alleging that CVS’s Caremark, Cigna’s Express Scripts and ...
The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up ...
Insulin, used by millions of Americans, has taken center stage in the high-stakes battle over health care costs. Though ...
The US stock markets opened lower on Friday, September 20, as investors held back after a jump in the previous session, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback